CXCR4: from B-cell development to B cell–mediated diseasesStéphane Giorgiutti, Vincent Gies, Anne‐Sophie Korganow et al.|Life Science Alliance|2024Cited by 36
Defective germinal center selection results in persistence of self-reactive B cells from the primary to the secondary repertoire in Primary Antiphospholipid SyndromeYannick Dieudonné, Vincent Gies, Raquel Lorenzetti et al.|Nature Communications|2024Cited by 8
Complex Allele with Additive Gain-of-Function STING1 Variants in a Patient with Cavitating Lung Lesions and AspergillosisAurélien Guffroy, Yves Hansmann, Bénédicte Gérard et al.|Journal of Clinical Immunology|2022Cited by 5
The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus modelsNassima Bekaddour, Jean‐Philippe Herbeuval, Vincent Rodeschini et al.|Frontiers in Immunology|2024Cited by 4
Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effectsBirgit Caspar, Jean‐Philippe Herbeuval, Vincent Rodeschini et al.|Molecular Pharmacology|2025Cited by 0